Psychometric analysis of the Korean version of the high-dose chemotherapy specific quality of life questionnaire module from the European Organization for Research and Treatment of Cancer (EORTC QLQ-HDC29)

Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
Kyung Im KimJung Mi Oh

Abstract

We evaluated the psychometric properties of the Korean version of the European Organization for Research and Treatment of Cancer high-dose chemotherapy specific quality of life questionnaire module (EORTC QLQ-HDC29) when implemented with Korean patients by conducting a multicenter, longitudinal study in three Korean hospitals. A total of 226 patients who scheduled to receive the HDC followed by hematopoietic stem cell transplantation (HSCT) were enrolled. The patients were asked to complete three questionnaires [the EORTC Core Questionnaire (QLQ-C30), QLQ-HDC29, and the Functional Assessment of Cancer Therapy-Bone Marrow Transplantation] at four points in time: before HSCT and 100, 180, and 365 days after HSCT. Standard validity and reliability analyses were performed. Internal consistency of the QLQ-HDC29 was generally acceptable, as tested by Cronbach's α, except for the scales body image and the inpatient issues. Cronbach's α values for the Korean version of the QLQ-HDC29 were almost in accordance with results of the original version, except for the scales body image (lower to the original QLQ-HDC29, α = 0.73) and impact on family (higher to the original QLQ-HDC29, α = 0.52). Known-group comparison analyses showed significan...Continue Reading

References

Sep 11, 1998·Bone Marrow Transplantation·C S NeitzertJ Avery
May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T L KissH A Messner
May 8, 2004·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Y H YunK West
May 20, 2004·JAMA : the Journal of the American Medical Association·Karen L SyrjalaPaul J Martin
Mar 21, 2006·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Heejung YooJungshin Lee
Nov 4, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G VelikovaUNKNOWN EORTC Quality of Life Group
May 28, 2008·Best Practice & Research. Clinical Haematology·K Scott Baker, Christopher J Fraser
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Edward ChowUNKNOWN EORTC Quality of Life Group
Mar 17, 2010·Bone Marrow Transplantation·S PalluaB Holzner
Nov 26, 2010·The New England Journal of Medicine·Ted A GooleyGeorge B McDonald
Mar 20, 2013·Haematologica·Alois GratwohlUNKNOWN Worldwide Network of Blood and Marrow Transplantation (WBMT)
Jun 17, 2014·Journal of Korean Medical Science·Yumi LeeSang-Yoon Park

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

© 2021 Meta ULC. All rights reserved